UBS Group’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
288,685
+32,192
| +13% | +$13.4K | ﹤0.01% | 5820 |
|
|
2025
Q1 | $160K | Sell |
256,493
-151,563
| -37% | -$94.4K | ﹤0.01% | 5455 |
|
|
2024
Q4 | $681K | Buy |
408,056
+378,816
| +1,296% | +$633K | ﹤0.01% | 4504 |
|
|
2024
Q3 | $53.2K | Buy |
29,240
+13,787
| +89% | +$25.1K | ﹤0.01% | 5581 |
|
|
2024
Q2 | $93.2K | Sell |
15,453
-13,621
| -47% | -$82.1K | ﹤0.01% | 5076 |
|
|
2024
Q1 | $324K | Sell |
29,074
-1,914
| -6% | -$21.3K | ﹤0.01% | 4391 |
|
|
2023
Q4 | $461K | Buy |
30,988
+19,794
| +177% | +$295K | ﹤0.01% | 4032 |
|
|
2023
Q3 | $53.7K | Sell |
11,194
-1,168
| -9% | -$5.61K | ﹤0.01% | 5124 |
|
|
2023
Q2 | $92.8K | Buy |
12,362
+2,319
| +23% | +$17.4K | ﹤0.01% | 5021 |
|
|
2023
Q1 | $45.4K | Buy |
10,043
+2,801
| +39% | +$12.7K | ﹤0.01% | 5447 |
|
|
2022
Q4 | $81.6K | Buy |
+7,242
| New | +$81.6K | ﹤0.01% | 5157 |
|
|
2022
Q2 | – | Sell |
-86,072
| Closed | -$1.46M | – | 9208 |
|
|
2022
Q1 | $1.46M | Sell |
86,072
-7,726
| -8% | -$131K | ﹤0.01% | 2923 |
|
|
2021
Q4 | $2.02M | Buy |
93,798
+86,532
| +1,191% | +$1.86M | ﹤0.01% | 2864 |
|
|
2021
Q3 | $537K | Buy |
7,266
+2,528
| +53% | +$187K | ﹤0.01% | 3687 |
|
|
2021
Q2 | $259K | Sell |
4,738
-14,210
| -75% | -$777K | ﹤0.01% | 4163 |
|
|
2021
Q1 | $1.4M | Buy |
18,948
+18,898
| +37,796% | +$1.39M | ﹤0.01% | 3056 |
|
|
2020
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 6860 |
|